Neuroendocrine-immune interactions are profoundly regulated by corticotropin-releasing hormone (CRH) indirectly, through activation of a global stress response, and directly, through pro-inflammatory actions on peripheral immune functions. The indirect effects of stress on immune/inflammatory responses occur via the stress-induced activation of the hypothalamicpituitary-adrenal (HPA) axis and the sympathetic/adrenomedullary system. We have demonstrated that glucocorticoids and catecholamines favor T helper 2 (TH2) over T helper 1 (TH1) immune cells and mediators, by controlling the production of specific key regulatory cytokines. This could explain the influences of chronic stress on the development, course, and pathology of certain allergic, autoimmune/inflammatory, infectious, and neoplastic diseases. We have also shown that 'immune CRH' is secreted peripherally and plays a direct immunomodulatory role as an autocrine or paracrine mediator of inflammation. Upon release from immune cells and peripheral sensory afferent and/or postganglionic sympathetic nerves, CRH acts locally to elicit pro-inflammatory responses. This would explain the triggering or exacerbation of certain allergic or vasokinetic states by acute stress.
Introduction
known relation between stress and the triggering or course of allergic and autoimmune/ inflammatory dis-CRH profoundly influences neuroendocrine-immune eases. interactions indirectly, through activation of a global stress response, and via direct effects on local inflammatory reactions. Activation of the stress system occurs Indirect effects of CRH and stress on immune/inflammatory responses within the central nervous system (CNS) in response to distinct bloodborne, neurosensory, and limbic signals.
As the primary regulator of corticotropin (ACTH) Release of hypothalamic CRH leads ultimately to syssecretion from the pituitary and, thus, glucocorticoid temic secretion of glucocorticoids, epinephrine and secretion from the adrenal gland, CRH modulates norepinephrine, which in turn influence immune/ immune/inflammatory reactions through receptorinflammatory reactions in a major fashion. Conversely, mediated actions of glucocorticoids on their target immune cell products, predominately tumor necrosis immune tissues and cells. Immunosuppressive and factor-␣ (TNF␣), interleukin-1 (IL-1) and interleukin anti-inflammatory properties of glucocorticoids have (IL-6), stimulate CRH secretion and, hence, activate made them invaluable therapeutic agents in numerous both the hypothalamic-pituitary-adrenal (HPA) axis diseases. Glucocorticoids prevent the migration of leuand the sympathetic nervous system during inflammakocytes from the circulation into extravascular fluid tory stress. 1, 2 spaces, reduce the accumulation of monocytes and graThe immuno-suppressive and anti-inflammatory nulocytes at inflammatory sites, and suppress the proeffects of stress are unequivocal and have been known duction and/or actions of many cytokines and for over 60 years. However, it is gradually becoming inflammatory mediators (reviewed in Ref. 1) . clear that stress does not simply suppress all aspects
In concert with glucocorticoids, catecholamines, the of immunity, but rather results in wide changes in end-products of the peripheral sympathetic/ immunocompetence and even exaggerated responsiveadrenomedullary system, also suppress select immune ness of certain components of the immune/ inflammaresponses through specific adrenergic receptor subtory reaction, as one would surmise from the welltypes expressed on immune cells. 3 Like other agents that stimulate intracellular cyclic AMP levels, ␤-adrenergic agonists suppress several immune functions, that dexamethasone, norepinephrine and epinephrine inhibited nergic receptor-mediated mechanism. In its immune role, IL-6 enhances antibody formation and the pro-LPS-induced IL-12 production by human peripheral blood mononuclear leukocytes ex vivo. Furthermore, duction of acute phase reactants by the liver. At the same time, IL-6 acts as an inhibitor and terminator of they showed that norepinephrine and epinephrine, but not dexamethasone, stimulated IL-10 production, suginflammation, by stimulating the secretion of glucocorticoids and IL-1 receptor antagonist (IL-1Ra) and by gesting that catecholamines directly stimulate differentiation of the TH2 subset. These results provide strong inhibiting the secretion of TNF␣ and IL-1. Glucocorticoids inhibit the production of IL-6 by evidence that stress hormones selectively amplify TH2 immune responses, while suppressing TH1 by altering macrophages/monocytes; however, the stimulatory effect of catecholamines predominates during stress. 4 have demonstrated that plasma IL-6 is induced by exercise and that IL-6 elevations are a feature of acute glucocorticoid deficiency, probably participating in the genesis of fatigue that characterizes both of these states. 4, 5 Epidemiological and experimental studies suggest that stress and stress hormones influence the development, course, and pathology of certain allergic, autoimmune/inflammatory, infectious and neoplastic diseases, by predominately stimulating a T helper 2 (TH2) as opposed to a T helper 1 (TH1) type response, ie by enhancing humoral more than cellular immunity. The TH1 response profile includes secretion of interferon-␥, interleukin-2, and lymphotoxin, which activate cytotoxic T lymphocytes, natural killer cells, and macrophages. In contrast, the TH2 response profile includes secretion of IL-4, IL-5, IL-6, and IL-10, and activation of B lymphocytes, eosinophils, and mast cells.
6 By influencing the selection of the T helper cell subtype, stress hormones help determine which type of immune response prevails.
7 Stress-induced selection of the type of immune response is enabled by the ability of specific TH1 and TH2 cytokines to inhibit the development of the reciprocal T helper cell subtype, while stimulating self-expansion.
The stress-induced dominance of TH2-type immune responses results from the control of specific key regulatory cytokines IFN-␥, IL-4, IL-10, and IL-12.
7,8 Both IL-12 and IFN-␥ stimulate the development of the TH1 phenotype, while suppressing the expression of the TH2 phenotype. Conversely, IL-4 stimulates the development of TH2 cells but suppresses TH1 cell differentiation from uncommitted CD4+ cells. IL-10, a product of TH2 cells and monocytes/macrophages, is also a immune responses. central CRH-induced suppression of natural killer cell cytotoxicity in rats occurs through activation of the 'Immune CRH' is secreted peripherally and plays a direct immuno-modulatory role as an autocrine or parsympathetic nervous system and is independent of HPA axis activation, since bilateral adrenalectomy did acrine mediator of inflammation. 1 Our laboratory has localized immunoreactive CRH (irCRH) in local not suppress cytotoxicity while pretreatment with a ganglionic blocker did prevent the suppression of natuimmune accessory cells in various experimental models of inflammation, including carrageenin-induced ral killer cell cytotoxicity by stress.
10
Normal and pathologic conditions associated with aseptic inflammation in Sprague-Dawley rats, and acute and chronic streptococcal cell wall-and adjuexcessive HPA axis activity and responses (see Table 1 ) are characterized by increased susceptibility to infecvant-induced arthritides and RP-16 induced uveitis in Lewis rats. Immunocytochemistry and HPLC also have tious agents and tumors with resistance to allergic and autoimmune/inflammatory diseases, suggesting TH1 verified irCRH in human tissues undergoing inflammatory processes, including joints of patients with suppression and TH2 predominance. Conversely, a defective HPA axis response leads to resistance to rheumatoid arthritis, thyroids of patients with Hashimoto thyroiditis, and colonic mucosa of patients with infections and neoplasms but increased susceptibility to allergic autoimmune/inflammatory diseases domiulcerative colitis.
1,8,12
Both CRH and CRH mRNA were demonstrated in rat nated by cellular immune responses, compatible with TH1 predominance. 1, 7, 8 These immune response proand mouse spleen and thymus and human peripheral blood leukocytes (reviewed in Ref. 1). In addition, files are respectively exhibited by Fischer and Lewis rats, two highly inbred strains selected for their resistmitogenic stimulation of human T lymphocytes was reported to result in CRH sysnthesis, 13 while CRH ance or vulnerability to inflammatory disease. In Lewis rats, hypothalamic CRH neurons respond poorly to mRNA was detected in chronically inflamed synovia in rats. 14 Generally, however, in early stages of inflammatory cytokines, stimulatory neurotransmitters or diverse exogenous stressors. The overall HPA axis inflammation there is a major discrepancy between the abundance of the peptide and the paucity of its mRNA, and sympathetic nervous system response to stress is decreased in these animals with decreased corticowhich is undetectable or present in minute quantities. The demonstration of CRH-like immunoreactivity in sterone and catecholamine production. The same animals develop TH1 type of autoimmune/inflammatory the dorsal horn of the spinal cord and dorsal root ganglia, 15, 16 and in sympathetic nerve cell bodies and symdiseases.
Human autoimmune diseases, such as rheumatoid pathetic ganglia 15, 17, 18 supports the hypothesis that the majority of immune CRH in early inflammation is of arthritis and autoimmune thyroiditis, tend to increase in incidence and severity in states associated with a peripheral nerve rather than immune cell origin. Immune CRH appears to have pro-inflammatory hyporesponsive HPA axis, eg during the postpartum period, when the HPA axis is suppressed.
11 Conactions, since systemic administration of rabbit anti-CRH sera caused suppression of both inflammatory exudate volume and cell number in carrageenin- 
